first glp 1 approval Ozempic is GLP-1 drug FDA-approved for kidney disease FDA Approves Oral Semaglutide as
Description
That is the answer for every FDA-approved oral GLP-1 tablet currently on the market

It works by simultaneously activating three receptors glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors producing significant reductions in body weight and improvements in metabolic markers
All results and testimonials are representative of individual altRx member experiences only.

This suggests a wide range of potential applications for drugs targeting AHR

doi: 10.1161/CIRCULATIONAHA.116.021887